Form 4: Kewaunee Scientific VP of HR Reports Vesting of Restricted Stock Units and Related Share Transactions

Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp, reported the vesting of 2,733 restricted stock units and the subsequent sale of 1,196 shares for tax withholding purposes.

Summary

• Elizabeth D. Phillips, VP Human Resources of Kewaunee Scientific Corp (KEQU), reported transactions involving common stock and restricted stock units.
• On June 30, 2025, 2,733 shares of common stock were acquired through the conversion of restricted stock units at a price of $0.
• This acquisition resulted from the vesting of various RSU grants: 1,756 units from the FY23 grant, 476 units from the FY24 grant, and 501 units from the FY25 grant.
• Following these acquisitions, the beneficial ownership of common stock was 16,324 shares.
• On July 1, 2025, 1,196 shares of common stock were disposed of at a price of $58.34 per share, likely to cover tax liabilities associated with the RSU vesting.
• After the disposal, the beneficial ownership of common stock was 15,128 shares.
• Remaining restricted stock units include 3,805 units from the FY24 grant and 3,259 units from the FY25 grant.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it reflects the successful vesting of executive compensation, indicating continued employment and potentially performance achievement. The subsequent sale for tax purposes is a routine, expected event and does not indicate negative sentiment.

Positives

• Vesting of 2,733 restricted stock units, converting into common stock, indicates successful achievement of service-based vesting conditions for the reporting person.
• The reporting person continues to hold a significant number of shares (15,128 common shares) and unvested restricted stock units (7,064 units), aligning her interests with shareholders.

Negatives

• The disposal of 1,196 shares of common stock, likely for tax withholding, reduces the direct shareholding of the reporting person.

Future Outlook

Future vesting of remaining Restricted Stock Units from the FY24 and FY25 grants is contingent upon continued employment and, for a portion of these grants, the achievement of specific performance goals over a three-year period.

Industry Context

This Form 4 filing reflects routine executive compensation practices within publicly traded companies, where restricted stock units are a common incentive mechanism to align executive interests with long-term shareholder value. The vesting and subsequent sale for tax purposes are standard procedures for such equity awards.

Stakeholder Impact

• Shareholders: The vesting and subsequent sale for tax purposes are routine executive compensation events and do not typically have a significant direct impact on share price or company strategy. It reflects the ongoing alignment of executive incentives with company performance.
• Employees: The report details compensation for a senior executive, which is part of the broader compensation structure.

Next Steps

• Continued vesting of remaining service-based Restricted Stock Units from the FY24 and FY25 grants on their respective annual installment dates.
• Potential vesting of performance-based Restricted Stock Units from the FY24 and FY25 grants upon the achievement of defined performance goals over their respective three-year periods.

Key Dates

Keywords

KEWAUNEE SCIENTIFIC CORP, KEQU, Elizabeth D. Phillips, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Common Stock, Executive Compensation, Share Ownership